ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
前日終値
$10.48
−$0.01 · -0.10%
日中の時刻はETです。市場データは遅延する場合があります。
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
日中レンジ
現在 $10.48
52週レンジ
現在 $10.48
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
60
適正価値
センチメント
52
まちまち
リスク
64
高リスク
モメンタム
60
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
日中レンジ
現在 $10.48
52週レンジ
現在 $10.48
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 3697.1万 USD | 3139万 USD | 2395.5万 USD | 2055.1万 USD | 1629.9万 USD |
| 売上原価 | 1427.9万 USD | 1226.8万 USD | 1034.1万 USD | 702万 USD | 517.6万 USD |
| 粗利益 | 2269.2万 USD | 1912.2万 USD | 1361.4万 USD | 1353.1万 USD | 1112.3万 USD |
| 研究開発 | 1389.7万 USD | 1239.2万 USD | 1170.9万 USD | 1089.4万 USD | 928.1万 USD |
| 販売・一般管理 | 3295.9万 USD | 2647.6万 USD | 2435.1万 USD | 1896.9万 USD | 1521.6万 USD |
| 営業費用 | 4685.6万 USD | 3886.8万 USD | 3606万 USD | 2986.3万 USD | 2449.7万 USD |
| 受取利息 | 121.3万 USD | 87.2万 USD | 38.6万 USD | — | — |
| 支払利息 | 238.8万 USD | — | — | 8.1万 USD | 97.3万 USD |
| 減価償却費と償却費 | 223.7万 USD | 190.3万 USD | 145.7万 USD | 77.7万 USD | 69.2万 USD |
| 営業利益 | −2416.4万 USD | −1974.6万 USD | −2244.6万 USD | −1633.2万 USD | −1337.4万 USD |
| 純利益 | −2554万 USD | −1891.4万 USD | −2208.9万 USD | −1643.5万 USD | −1441万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$23.50
上昇余地(124.24%)評価サンプルは3件と限定的です
| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2016年7月27日 | 1:40 | — | — |
発効済み 2016年7月27日
1:40
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI1292.66万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM769.6万0.01%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF529.92万0.01%954億 USD0.05%$235+0.80%
iShares Russell 2000 Growth ETFIWO276.64万0.02%139.17億 USD0.24%$356.78+0.94%
Vanguard Russell 2000 ETFVTWO245.37万0.01%180億 USD0.06%$112.66+0.50%
State Street SPDR S&P Health Care Equipment ETFXHE142.25万0.82%1.74億 USD0.35%$89.47+1.51%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP128.69万0.05%26.06億 USD0.20%$66.35+1.13%
iShares Micro-Cap ETFIWC92.64万0.07%13.17億 USD0.60%$183+0.11%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
Vanguard Russell 2000 ETFVTWO
State Street SPDR S&P Health Care Equipment ETFXHE
State Street SPDR S&P Kensho New Economies Composite ETFKOMP
iShares Micro-Cap ETFIWCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。